protoporphyrin ix has been researched along with tretinoin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Hasan, T; Maytin, EV; O'Donnell, D; Ortel, B; Sharlin, D; Sinha, AK | 1 |
| Gerritsen, RM; Kanis, JH; Kleinpenning, MM; Smits, T; van de Kerkhof, P; van Erp, PE | 1 |
3 other study(ies) available for protoporphyrin ix and tretinoin
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells.
Topics: Aminolevulinic Acid; Cell Differentiation; Flow Cytometry; Humans; Male; Metribolone; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Testosterone Congeners; Tretinoin; Tumor Cells, Cultured; Vitamin D | 2002 |
The effects of keratolytic pretreatment prior to fluorescence diagnosis and photodynamic therapy with aminolevulinic acid-induced porphyrins in psoriasis.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Analysis of Variance; Bandages, Hydrocolloid; Biopsy, Needle; Female; Fluorescence; Humans; Immunohistochemistry; Keratolytic Agents; Male; Middle Aged; Photochemotherapy; Pilot Projects; Probability; Protoporphyrins; Psoriasis; Skin Absorption; Treatment Outcome; Tretinoin | 2010 |